Open the Channel to High-Value Biopharma Partnerships
The ion channel landscape is entering a new phase of momentum, driven by clinical breakthroughs, increased investment, and expanding pipelines across CNS, cardiovascular, renal, and emerging indications.
However, developers still face significant challenges, including achieving subtype selectivity, improving model-to-human translatability, managing safety risks, and integrating advanced electrophysiology, structural biology, and screening technologies.
As a result, biopharma teams are actively seeking specialized partners to accelerate discovery and development.
The Ion Channel–Targeted Drug Development Summit brought together a technically focused audience of decision-makers and scientific leaders, providing a platform to demonstrate how your solutions enhance assay design, strengthen translational strategies, and drive more confident development decisions.
Position your company as a key partner in 2027, enabling the next generation of ion channel therapeutics.
What you Missed in 2026?
Connect With Decision-Makers Driving Ion Channel Innovation
Engage directly with senior scientists and R&D leaders from biotech, pharma, and academia actively advancing ion channel pipelines across multiple indications.
Showcase Your Technologies & Capabilities
Demonstrate how your platform or services solve key bottlenecks, from electrophysiology workflows and structural insights to translational modelling and screening strategies.
Position Your Brand at the Centre of Scientific Discussion
Benefit from prominent visibility across presentations, panels, exhibition space, and event branding, ensuring your solution is front-of-mind for engaged buyers.
Position Your Brand at the Centre of Scientific Discussion
Benefit from prominent visibility across presentations, panels, exhibition space, and event branding, ensuring your solution is front-of-mind for engaged buyers.
Gain Real-Time Market Insights
Hear directly from leaders at the cutting edge of ion channel drug discovery to understand emerging trends, investment priorities, and evolving scientific needs.
Key Interest Areas
Our attendees from biopharma are looking for service and solution providers with capabilities in the below areas but not limited to:
Electrophysiology & Membrane Protein Assays
Preclinical & Translational CRO Services
Discovery Biology & Medicinal Chemistry
Structural Biology & Characterization
AI, Modelling & Computational Drug Discovery
In Vitro Pharmacology & Functional Screening
2026 Attending Companies Included
Bespoke Partnership Opportunities Available Include:
We offer a range of sponsorship opportunities from thought leadership and exhibition space to bespoke networking experiences, allowing you to build a package aligned with your commercial goals.